1025878-20-9

Basic information

• Product Name: 5-[N'-(3,5-difluorophenylacetyl)-L-alaninyl]amino-5,7-dihydro-6H,7H-dibenz[b,d]azepin-6-one
• CAS NO: 1025878-20-9
• Molecular Weight: 449.457
• Mol File: 1025878-20-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 5-[N'-(3,5-difluorophenylacetyl)-L-alaninyl]amino-5,7-dihydro-6H,7H-dibenz[b,d]azepin-6-one(CAS DataBase Reference)
• NIST Chemistry Reference: 5-[N'-(3,5-difluorophenylacetyl)-L-alaninyl]amino-5,7-dihydro-6H,7H-dibenz[b,d]azepin-6-one(1025878-20-9)
• EPA Substance Registry System: 5-[N'-(3,5-difluorophenylacetyl)-L-alaninyl]amino-5,7-dihydro-6H,7H-dibenz[b,d]azepin-6-one(1025878-20-9)

Safety Data

• Hazardous Substances Data: 1025878-20-9(Hazardous Substances Data)

Upstream product

• 1026250-02-1 5-(N-Boc-Amino)-5,7-dihydro-6H,7H-dibenz[b,d]azepin-6-one 
• 762-75-4 tert-butyl formate 
• 208124-34-9 N-(3,5-Difluorophenylacetyl)-L-alanine 

Relevant articles and documents

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds

Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.